Safety and Efficacy of Probiotics in Bangladeshi Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Lactobacillus reuteri DSM 17938

10\^8 CFU

DIETARY_SUPPLEMENT

Bifidobacterium longum infantis

10\^9 CFU

Trial Locations (1)

Unknown

International Center for Diarrheal Disease Research, Bangladesh, Dhaka

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Thrasher Research Fund

OTHER

lead

Stanford University

OTHER

NCT01899378 - Safety and Efficacy of Probiotics in Bangladeshi Infants | Biotech Hunter | Biotech Hunter